CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,201,742 | +40.1% | 45,868 | +5.1% | 0.06% | +88.2% |
Q3 2022 | $858,000 | +387.5% | 43,634 | +333.8% | 0.03% | +325.0% |
Q2 2022 | $176,000 | -61.8% | 10,059 | -64.3% | 0.01% | -60.0% |
Q1 2022 | $461,000 | +112.4% | 28,200 | +65.9% | 0.02% | +25.0% |
Q3 2021 | $217,000 | – | 17,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |